JEFFREY FOLICK - 24 Jun 2021 Form 3 Insider Report for Bright Health Group Inc. (NEUE)

Role
Director
Signature
/s/ Eric Halverson for Jeff Folick, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
3
Filing time
24 Jun 2021, 21:57:09 UTC
Previous filing
30 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BHG Common Stock 413,927 24 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BHG Series A Preferred Stock 24 Jun 2021 Common Stock 156,570 Direct F1
holding BHG Series B Preferred Stock 24 Jun 2021 Common Stock 30,941 Direct F2
holding BHG Series C Preferred Stock 24 Jun 2021 Common Stock 32,079 Direct F2
holding BHG Series D Preferred Stock 24 Jun 2021 Common Stock 13,311 Direct F2
holding BHG Stock Options (Right to Buy) 24 Jun 2021 Common Stock 125,220 $0.6267 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Each share of the Issuer's Series A Preferred Stock will automatically convert into shares of the Issuer's common stock ("Common Stock") on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
F2 Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, and Series D Preferred Stock will automatically convert into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
F3 These stock options vest over four years as follows: (a) 25% vested on April 3, 2019 (one year after the grant date), and (b) 1/48 of the original grant amount (546,411) vests in monthly installments for the following three years.